Clinical Trial Update: Effects of Lutein in Retinitis Pigmentosa [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trials evaluating lutein for retinitis pigmentosa have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• Lutein (lutein)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: COMPLETED